MovDisordV3, Main, Merge, bibRecord, 003387

Homozygous SCA 2 mutations changes phenotype and hastens progression

Identifieur interne : 003387 ( Main/Merge ); précédent : 003386; suivant : 003388

Homozygous SCA 2 mutations changes phenotype and hastens progression

Auteurs : Mona Ragothaman [Inde] ; Uday Muthane [Niger, Inde]

Source :

Movement Disorders [ 0885-3185 ] ; 2008-04-15.

RBID : ISTEX:4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8

English descriptors

KwdEn :
- Antiparkinson Agents (therapeutic use), Dementia (diagnosis), Dementia (genetics), Disease Progression, Dyskinesias (diagnosis), Dyskinesias (genetics), Female, Follow-Up Studies, Homozygote, Humans, Levodopa (therapeutic use), Male, Mutation, Nerve Tissue Proteins (genetics), Ocular Motility Disorders (diagnosis), Ocular Motility Disorders (genetics), Parkinsonian Disorders (diagnosis), Parkinsonian Disorders (drug therapy), Parkinsonian Disorders (genetics), Phenotype, Psychotic Disorders (diagnosis), Psychotic Disorders (genetics), Spinocerebellar Degenerations (genetics), Spinocerebellar Degenerations (physiopathology).
MESH :
- chemical , genetics : Nerve Tissue Proteins.
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- diagnosis : Dementia, Dyskinesias, Ocular Motility Disorders, Parkinsonian Disorders, Psychotic Disorders.
- drug therapy : Parkinsonian Disorders.
- genetics : Dementia, Dyskinesias, Ocular Motility Disorders, Parkinsonian Disorders, Psychotic Disorders, Spinocerebellar Degenerations.
- physiopathology : Spinocerebellar Degenerations.
- Disease Progression, Female, Follow-Up Studies, Homozygote, Humans, Male, Mutation, Phenotype.

Url:

https://api.istex.fr/document/4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8/fulltext/pdf

DOI: 10.1002/mds.21950

Links to Exploration step

ISTEX:4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Homozygous SCA 2 mutations changes phenotype and hastens progression</title>
<author><name sortKey="Ragothaman, Mona" sort="Ragothaman, Mona" uniqKey="Ragothaman M" first="Mona" last="Ragothaman">Mona Ragothaman</name>
</author>
<author><name sortKey="Muthane, Uday" sort="Muthane, Uday" uniqKey="Muthane U" first="Uday" last="Muthane">Uday Muthane</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21950</idno>
<idno type="url">https://api.istex.fr/document/4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003E60</idno>
<idno type="wicri:Area/Istex/Curation">003E60</idno>
<idno type="wicri:Area/Istex/Checkpoint">001365</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Ragothaman M:homozygous:sca:mutations</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18265007</idno>
<idno type="wicri:Area/PubMed/Corpus">002317</idno>
<idno type="wicri:Area/PubMed/Curation">002317</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002259</idno>
<idno type="wicri:Area/Ncbi/Merge">002042</idno>
<idno type="wicri:Area/Ncbi/Curation">002042</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002042</idno>
<idno type="wicri:Area/Main/Merge">003387</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Homozygous SCA 2 mutations changes phenotype and hastens progression</title>
<author><name sortKey="Ragothaman, Mona" sort="Ragothaman, Mona" uniqKey="Ragothaman M" first="Mona" last="Ragothaman">Mona Ragothaman</name>
<affiliation wicri:level="1"><country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Neurology, National Institute of Mental Health and Neuroscience, Bangalore</wicri:regionArea>
<wicri:noRegion>Bangalore</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Muthane, Uday" sort="Muthane, Uday" uniqKey="Muthane U" first="Uday" last="Muthane">Uday Muthane</name>
<affiliation wicri:level="1"><country wicri:rule="url">Niger</country>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Neurology, National Institute of Mental Health and Neuroscience, Bangalore</wicri:regionArea>
<wicri:noRegion>Bangalore</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-04-15">2008-04-15</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="770">770</biblScope>
<biblScope unit="page" to="771">771</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8</idno>
<idno type="DOI">10.1002/mds.21950</idno>
<idno type="ArticleID">MDS21950</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (therapeutic use)</term>
<term>Dementia (diagnosis)</term>
<term>Dementia (genetics)</term>
<term>Disease Progression</term>
<term>Dyskinesias (diagnosis)</term>
<term>Dyskinesias (genetics)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Homozygote</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Mutation</term>
<term>Nerve Tissue Proteins (genetics)</term>
<term>Ocular Motility Disorders (diagnosis)</term>
<term>Ocular Motility Disorders (genetics)</term>
<term>Parkinsonian Disorders (diagnosis)</term>
<term>Parkinsonian Disorders (drug therapy)</term>
<term>Parkinsonian Disorders (genetics)</term>
<term>Phenotype</term>
<term>Psychotic Disorders (diagnosis)</term>
<term>Psychotic Disorders (genetics)</term>
<term>Spinocerebellar Degenerations (genetics)</term>
<term>Spinocerebellar Degenerations (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dementia</term>
<term>Dyskinesias</term>
<term>Ocular Motility Disorders</term>
<term>Parkinsonian Disorders</term>
<term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Dementia</term>
<term>Dyskinesias</term>
<term>Ocular Motility Disorders</term>
<term>Parkinsonian Disorders</term>
<term>Psychotic Disorders</term>
<term>Spinocerebellar Degenerations</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Spinocerebellar Degenerations</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Progression</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Homozygote</term>
<term>Humans</term>
<term>Male</term>
<term>Mutation</term>
<term>Phenotype</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<double doi="10.1002/mds.21950"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Homozygous SCA 2 mutations changes phenotype and hastens progression</title>
<author><name sortKey="Ragothaman, Mona" sort="Ragothaman, Mona" uniqKey="Ragothaman M" first="Mona" last="Ragothaman">Mona Ragothaman</name>
</author>
<author><name sortKey="Muthane, Uday" sort="Muthane, Uday" uniqKey="Muthane U" first="Uday" last="Muthane">Uday Muthane</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.21950</idno>
<idno type="url">https://api.istex.fr/document/4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003E60</idno>
<idno type="wicri:Area/Istex/Curation">003E60</idno>
<idno type="wicri:Area/Istex/Checkpoint">001365</idno>
<idno type="wicri:doubleKey">0885-3185:2008:Ragothaman M:homozygous:sca:mutations</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Homozygous SCA 2 mutations changes phenotype and hastens progression</title>
<author><name sortKey="Ragothaman, Mona" sort="Ragothaman, Mona" uniqKey="Ragothaman M" first="Mona" last="Ragothaman">Mona Ragothaman</name>
<affiliation wicri:level="1"><country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Neurology, National Institute of Mental Health and Neuroscience, Bangalore</wicri:regionArea>
<wicri:noRegion>Bangalore</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Muthane, Uday" sort="Muthane, Uday" uniqKey="Muthane U" first="Uday" last="Muthane">Uday Muthane</name>
<affiliation wicri:level="1"><country wicri:rule="url">Niger</country>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Neurology, National Institute of Mental Health and Neuroscience, Bangalore</wicri:regionArea>
<wicri:noRegion>Bangalore</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-04-15">2008-04-15</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="770">770</biblScope>
<biblScope unit="page" to="771">771</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8</idno>
<idno type="DOI">10.1002/mds.21950</idno>
<idno type="ArticleID">MDS21950</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
</ISTEX>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Homozygous SCA 2 mutations changes phenotype and hastens progression.</title>
<author><name sortKey="Ragothaman, Mona" sort="Ragothaman, Mona" uniqKey="Ragothaman M" first="Mona" last="Ragothaman">Mona Ragothaman</name>
</author>
<author><name sortKey="Muthane, Uday" sort="Muthane, Uday" uniqKey="Muthane U" first="Uday" last="Muthane">Uday Muthane</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="doi">10.1002/mds.21950</idno>
<idno type="RBID">pubmed:18265007</idno>
<idno type="pmid">18265007</idno>
<idno type="wicri:Area/PubMed/Corpus">002317</idno>
<idno type="wicri:Area/PubMed/Curation">002317</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002259</idno>
<idno type="wicri:Area/Ncbi/Merge">002042</idno>
<idno type="wicri:Area/Ncbi/Curation">002042</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">002042</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Homozygous SCA 2 mutations changes phenotype and hastens progression.</title>
<author><name sortKey="Ragothaman, Mona" sort="Ragothaman, Mona" uniqKey="Ragothaman M" first="Mona" last="Ragothaman">Mona Ragothaman</name>
</author>
<author><name sortKey="Muthane, Uday" sort="Muthane, Uday" uniqKey="Muthane U" first="Uday" last="Muthane">Uday Muthane</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (therapeutic use)</term>
<term>Dementia (diagnosis)</term>
<term>Dementia (genetics)</term>
<term>Disease Progression</term>
<term>Dyskinesias (diagnosis)</term>
<term>Dyskinesias (genetics)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Homozygote</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Male</term>
<term>Mutation</term>
<term>Nerve Tissue Proteins (genetics)</term>
<term>Ocular Motility Disorders (diagnosis)</term>
<term>Ocular Motility Disorders (genetics)</term>
<term>Parkinsonian Disorders (diagnosis)</term>
<term>Parkinsonian Disorders (drug therapy)</term>
<term>Parkinsonian Disorders (genetics)</term>
<term>Phenotype</term>
<term>Psychotic Disorders (diagnosis)</term>
<term>Psychotic Disorders (genetics)</term>
<term>Spinocerebellar Degenerations (genetics)</term>
<term>Spinocerebellar Degenerations (physiopathology)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Nerve Tissue Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Dementia</term>
<term>Dyskinesias</term>
<term>Ocular Motility Disorders</term>
<term>Parkinsonian Disorders</term>
<term>Psychotic Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinsonian Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Dementia</term>
<term>Dyskinesias</term>
<term>Ocular Motility Disorders</term>
<term>Parkinsonian Disorders</term>
<term>Psychotic Disorders</term>
<term>Spinocerebellar Degenerations</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Spinocerebellar Degenerations</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Disease Progression</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Homozygote</term>
<term>Humans</term>
<term>Male</term>
<term>Mutation</term>
<term>Phenotype</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
</PubMed>
</double>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003387 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003387 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Merge
   |type=    RBID
   |clé=     ISTEX:4C9791D1AC7B8362E0C910B7408F05C7FBC0DDB8
   |texte=   Homozygous SCA 2 mutations changes phenotype and hastens progression
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Homozygous SCA 2 mutations changes phenotype and hastens progression

Homozygous SCA 2 mutations changes phenotype and hastens progression

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.